WHO

WHO names COVID-19 variants first found in India as 'Kappa' and 'Delta'

The WHO's move came nearly three weeks after India objected to the B.1.617 mutant of the novel coronavirus being termed an 'Indian Variant'.

published on : 1st June 2021

WHO chief Tedros Adhanom Ghebreyesus concedes 'slow' response to Congo sex abuse claims

Diplomats have already pressed WHO Director-General Tedros Adhanom Ghebreyesus on the issue behind closed-doors.

published on : 28th May 2021

Delegates approve 16 per cent increase to WHO budget

More than 90% of WHO's funding is tied to specific health issues, and the agency often struggles to respond to urgent crises.

published on : 28th May 2021

India supports WHO's call for detailed studies on origins of coronavirus: External Affairs Ministry

External Affairs Ministry spokesperson Arindam Bagchi said the follow up of the WHO report and further studies deserve the understanding and cooperation of all.

published on : 28th May 2021

Will US politics bury or expose truth?

Being a disciplined writer he did not touch the most sensitive subject the link between the Wuhan Institute of Virology (WIV) and the PLA (Chinese military), which is now coming out.

published on : 28th May 2021

B.1.617 COVID-19 variant, first detected in India, now found in 53 countries: WHO

WHO has declared B.1.617 as a "variant of concern" and the update noted that this variant has "increased transmissibility" and disease severity is "under investigation".

published on : 27th May 2021

Covid-19: The villain, bats or bat lady

Even now, what the world knows about the mysterious virus 18 months after it broke out in Wuhan city in China, is that it is mysterious.

published on : 27th May 2021

Bharat Biotech expects EUL from WHO for Covaxin in July-September

Bharat Biotech said regulatory approvals for Covaxin are in process in more than 60 countries, including the USA, Brazil and Hungary, among others.

published on : 25th May 2021

WHO says 'more information' required from Bharat Biotech for emergency use listing of Covaxin

According to the WHO, submissions to it for prequalification or listing under the emergency use procedure are confidential.

published on : 25th May 2021

Bharat Biotech submitted 90 per cent of documents to WHO for emergency use listing for Covaxin: Sources

Noting that Covaxin has already received regulatory approval from 11 countries, sources said there was also interest from other 11 companies in seven nations for technology transfer and production.

published on : 24th May 2021

Vaccinate at least 10 per cent of population by September in every country: WHO

He urged those countries that have large stocks of vaccines to share them, and greater cooperation to scale up production and distribution of the jabs. ​

published on : 24th May 2021

Case fatality rate of COVID in J&K lower than other states: WHO official

Dr Ashiq Rashid Mir, Surveillance Medical Officer, expressed optimism over the recovery rate of positive cases along with less case fatality rate compared to the rest of the states.

published on : 23rd May 2021

Government widened COVID vaccination drive without considering stock, WHO guidelines, says Serum Institute

Speaking at an e-summit organised by Heal Health, Serum Institute of India official Suresh Jadhav said the country should have followed the WHO guidelines and prioritised vaccination accordingly.

published on : 21st May 2021

Vaccines stop variants but overseas travel still not safe: WHO

The so-called Indian variant, which might be more transmissible, has now been identified in at least 26 of the 53 countries in the WHO Europe region.

published on : 20th May 2021

Madhya Pradesh gets 100 oxygen concentrators from WHO for treatment of COVID patients

Madhya Pradesh minister Vishvas Sarang was present at the government drug store here, where these 100 concentrators were delivered.

published on : 19th May 2021
 < 7 8 9 10 1112 13 14 15 16 > 
edexworks